SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
216 hedge funds and large institutions have $2.25B invested in Sage Therapeutics in 2020 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 84 increasing their positions, 55 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
4.37% less ownership
Funds ownership: 108.42% → 104.05% (-4.4%)
6% less funds holding
Funds holding: 229 → 216 (-13)
19% less first-time investments, than exits
New positions opened: 46 | Existing positions closed: 57
Holders
216
Holding in Top 10
3
Calls
$30.5M
Puts
$21.9M
Top Buyers
| 1 | +$71.1M | |
| 2 | +$48.1M | |
| 3 | +$21.8M | |
| 4 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$20.8M |
| 5 |
BlackRock
New York
|
+$18.2M |
Top Sellers
| 1 | -$135M | |
| 2 | -$50.4M | |
| 3 | -$34.9M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$28.7M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$22.7M |